Ya know, fity... some peeps just want to be spoon-fed
Ya know, fity... some peeps just want to be spoon-fed "Bold Faced" information 24/7.
They are not willing to be teased with breadcrumbs while utilizing grey matter to deduce the "Big Picture".
This is also why censoring this board is a disservice. It took me two tours of duty to realize this board should not have a moderator.
One requirement of membership should be a one week stint (maximum) of moderating a message board that is under attack by organized bashers.
The "modérateur de la semaine" would soon find out no-one will be pleased, having both sides turn on them when adhering to the all-encompassing "Terms and Conditions" displayed by the site. One side of the argument displayed, the response lost, intent and motive skewed by an incomplete source of data for one to formulate a concise decision, the board wallows in a Mumbo-Jumbo pit of incomprehensible tangents.
Do you believe the "company people" are pleased with the bits and pieces" they are treated with from time to time while waiting out this most arduous process DECN has before it?
I do...
Yet
I do also succumb to frustration from time to time when "things" don't go exactly as I perceived they would. This is evident in posts past. We all have our "moments"...
BUT
The campaign to constantly harangue, while attempting to find fault in every move the company makes, points in the direction of a very different modus operandi
while squelching the efforts of the one who tosses the crumbs...
to those who quietly absorb the offerings...
and I truly believe there are many of those whose font never appears on the display before me, you, and the rest of the board.
and it those...
who miss the breadcrumbs the most.
*SansGrinz*
2
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Recent Developments in AI and Digital Innovation by ICON plc ICON plc, a globally recognized clinical research organization (NASDAQ: ICLR), has recently conducted an extensive survey exploring the integration of Artificial Intelligence (AI) and digital tools within clinical research. Engaging with over 100 professionals in the biotech and pharmaceutical industries across...
Continue Reading
Tesla's License Suspension in California Recently, a court in California announced a significant development affecting Tesla Inc. (NASDAQ: TSLA). The court decided to suspend Tesla's license to sell vehicles for 30 days due to a lawsuit concerning misleading claims about the company's Full Self-Driving (FSD) technology. If Tesla does not adapt its policies within 90 days,...
Continue Reading
Sunnova Energy Experiences Financial Struggles Sunnova Energy International Inc. (NOVA) has encountered a challenging period, with its shares trading lower in the premarket on Monday following a disappointing report detailing its fourth quarter and full-year financial results. The financial landscape for Sunnova shows a revenue of $224.127 million, which unfortunately...
Continue Reading
Kerusso's Inspiring Charitable Contributions in 2025 Kerusso Activewear, a prominent Christian apparel and gift brand, has ended the year with a remarkable achievement of over $400,000 in charitable contributions. This reflects their steadfast commitment to enriching lives through faith-based approaches and generous support for individuals in need. Growing Demand for...
Continue Reading
Prelude Therapeutics Partners with Incyte on JAK2V617F Program Incyte establishes exclusive option to acquire Prelude’s innovative programs These inhibitors have the potential to modify disease outcomes in patients with myeloproliferative neoplasms (MPNs) Prelude Therapeutics, a clinical-stage oncology company, has recently made headlines with an exciting announcement...
Continue Reading